The First Affiliated Hospital Of Xinxiang Medical College
Clinical trials sponsored by The First Affiliated Hospital Of Xinxiang Medical College, explained in plain language.
-
Could a common fruit acid boost cancer immunotherapy?
Disease control Not yet recruitingThis early-phase study tests whether adding malic acid (a natural fruit acid) to standard immunotherapy is safe and helps control tumors in people with solid cancers like colorectal, lung, or melanoma. About 30 adults currently on immunotherapy will take oral malic acid. Research…
Phase: EARLY_PHASE1 • Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Disease control
Last updated May 16, 2026 23:53 UTC
-
Silk and collagen patch aims to rebuild lost jawbone
Disease control Not yet recruitingThis study tests a new silk-reinforced collagen membrane designed to help regrow bone in the jaw. It is for people with severe gum disease who have bone loss around their teeth. The membrane is placed during a dental procedure to guide the body's natural bone healing. The goal is…
Phase: NA • Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Disease control
Last updated May 16, 2026 23:38 UTC
-
Tooth stem cells could regrow gum and bone without surgery
Disease control Not yet recruitingThis study tests whether injecting stem cells from donated teeth can help regrow gum and bone damaged by severe gum disease (periodontitis). Thirty adults with deep gum pockets and bone loss will receive the injection. The goal is to offer a less invasive alternative to tradition…
Phase: NA • Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New drug combo may make gut scopes safer for seniors
Symptom relief Not yet recruitingThis study tests whether a new combination of sedative and painkiller drugs can make deep sedation safer for elderly patients (ages 60-90) undergoing a procedure called ERCP, which treats bile duct problems. The goal is to reduce breathing complications and speed up recovery comp…
Phase: NA • Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Symptom relief
Last updated May 16, 2026 23:54 UTC
-
New anesthesia combo may reduce risks during chest surgery
Symptom relief Not yet recruitingThis study tests whether a newer anesthesia drug, remimazolam, combined with alfentanil, is safer than the standard propofol combination for chest surgery. The goal is to see if it lowers the chance of low oxygen levels and low blood pressure during the procedure. About 50 adults…
Phase: PHASE4 • Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Symptom relief
Last updated May 16, 2026 23:52 UTC
-
New combo targets colorectal cancer: serine joins chemo in early trial
Symptom relief Not yet recruitingThis early-stage trial tests whether adding serine to standard chemotherapy is safe for people with advanced colorectal cancer. About 20 adults will take serine by mouth alongside their usual treatment. The main goal is to check for side effects and find the best dose for future …
Phase: PHASE1 • Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Symptom relief
Last updated May 16, 2026 23:50 UTC
-
New burn dressing aims to speed healing and ease itching
Symptom relief Not yet recruitingThis study will test a new type of bandage made from a special gel (hydrogel) for treating first and shallow second-degree burns. The goal is to see if it helps the burn heal faster and reduces itching. About 30 adults with burns will take part, and their healing will be tracked …
Phase: NA • Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
New gel aims to lighten melasma with fewer side effects
Symptom relief Not yet recruitingThis study tests a new gel for melasma, a skin condition causing dark patches on the face. The gel combines tranexamic acid, aloe, and a penetration enhancer to improve effectiveness and reduce side effects. Ten women with melasma will apply the gel for 12 weeks, and doctors will…
Phase: NA • Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Symptom relief
Last updated May 05, 2026 11:57 UTC
-
Cancer Patients' mental health: scientists hunt for biomarkers
Knowledge-focused Not yet recruitingThis study aims to find biological markers (proteins from tumors) linked to anxiety and depression in people with solid tumors. Researchers will collect tumor tissue and blood samples from 100 adult patients and combine that with psychological assessments. The goal is to better u…
Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC